United States Doxorubicin Market Report 2017

October 2017 | 104 pages | ID: U10FCAE3292EN
QYResearch

Abstracts

In this report, the United States Doxorubicin market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Doxorubicin in these regions, from 2012 to 2022 (forecast).

United States Doxorubicin market competition by top manufacturers/players, with Doxorubicin sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Pfizer
• Johnson & Johnson
• Sun Pharmaceutical Industries
• Meiji Seika Pharma
• MicroBiopharm Japan
• Teva
• Boryung
• Synbias Pharma
• Sterling
• LINGNAN Pharmaceutical

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Doxorubicin Injection 10mg
• Doxorubicin Injection 50mg

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Doxorubicin for each application, including

• Multiple Myeloma
• Kaposi Sarcoma
• Leukemia
• Bone Sarcoma
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Doxorubicin Market Report 2017

1 DOXORUBICIN OVERVIEW

1.1 Product Overview and Scope of Doxorubicin
1.2 Classification of Doxorubicin by Product Category
  1.2.1 United States Doxorubicin Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Doxorubicin Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Doxorubicin Injection 10mg
  1.2.4 Doxorubicin Injection 50mg
1.3 United States Doxorubicin Market by Application/End Users
  1.3.1 United States Doxorubicin Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Multiple Myeloma
  1.3.3 Kaposi Sarcoma
  1.3.4 Leukemia
  1.3.5 Bone Sarcoma
  1.3.6 Others
1.4 United States Doxorubicin Market by Region
  1.4.1 United States Doxorubicin Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Doxorubicin Status and Prospect (2012-2022)
  1.4.3 Southwest Doxorubicin Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Doxorubicin Status and Prospect (2012-2022)
  1.4.5 New England Doxorubicin Status and Prospect (2012-2022)
  1.4.6 The South Doxorubicin Status and Prospect (2012-2022)
  1.4.7 The Midwest Doxorubicin Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Doxorubicin (2012-2022)
  1.5.1 United States Doxorubicin Sales and Growth Rate (2012-2022)
  1.5.2 United States Doxorubicin Revenue and Growth Rate (2012-2022)

2 UNITED STATES DOXORUBICIN MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Doxorubicin Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Doxorubicin Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Doxorubicin Average Price by Players/Suppliers (2012-2017)
2.4 United States Doxorubicin Market Competitive Situation and Trends
  2.4.1 United States Doxorubicin Market Concentration Rate
  2.4.2 United States Doxorubicin Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Doxorubicin Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES DOXORUBICIN SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Doxorubicin Sales and Market Share by Region (2012-2017)
3.2 United States Doxorubicin Revenue and Market Share by Region (2012-2017)
3.3 United States Doxorubicin Price by Region (2012-2017)

4 UNITED STATES DOXORUBICIN SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Doxorubicin Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Doxorubicin Revenue and Market Share by Type (2012-2017)
4.3 United States Doxorubicin Price by Type (2012-2017)
4.4 United States Doxorubicin Sales Growth Rate by Type (2012-2017)

5 UNITED STATES DOXORUBICIN SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Doxorubicin Sales and Market Share by Application (2012-2017)
5.2 United States Doxorubicin Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES DOXORUBICIN PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Pfizer
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Doxorubicin Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Pfizer Doxorubicin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Johnson & Johnson
  6.2.2 Doxorubicin Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Johnson & Johnson Doxorubicin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Sun Pharmaceutical Industries
  6.3.2 Doxorubicin Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Sun Pharmaceutical Industries Doxorubicin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Meiji Seika Pharma
  6.4.2 Doxorubicin Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Meiji Seika Pharma Doxorubicin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 MicroBiopharm Japan
  6.5.2 Doxorubicin Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 MicroBiopharm Japan Doxorubicin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Teva
  6.6.2 Doxorubicin Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Teva Doxorubicin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Boryung
  6.7.2 Doxorubicin Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Boryung Doxorubicin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Synbias Pharma
  6.8.2 Doxorubicin Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Synbias Pharma Doxorubicin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Sterling
  6.9.2 Doxorubicin Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Sterling Doxorubicin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 LINGNAN Pharmaceutical
  6.10.2 Doxorubicin Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 LINGNAN Pharmaceutical Doxorubicin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview

7 DOXORUBICIN MANUFACTURING COST ANALYSIS

7.1 Doxorubicin Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Doxorubicin

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Doxorubicin Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Doxorubicin Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES DOXORUBICIN MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Doxorubicin Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Doxorubicin Sales Volume Forecast by Type (2017-2022)
11.3 United States Doxorubicin Sales Volume Forecast by Application (2017-2022)
11.4 United States Doxorubicin Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Doxorubicin
Figure United States Doxorubicin Market Size (K Units) by Type (2012-2022)
Figure United States Doxorubicin Sales Volume Market Share by Type (Product Category) in 2016
Figure Doxorubicin Injection 10mg Product Picture
Figure Doxorubicin Injection 50mg Product Picture
Figure United States Doxorubicin Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Doxorubicin by Application in 2016
Figure Multiple Myeloma Examples
Table Key Downstream Customer in Multiple Myeloma
Figure Kaposi Sarcoma Examples
Table Key Downstream Customer in Kaposi Sarcoma
Figure Leukemia Examples
Table Key Downstream Customer in Leukemia
Figure Bone Sarcoma Examples
Table Key Downstream Customer in Bone Sarcoma
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Doxorubicin Market Size (Million USD) by Region (2012-2022)
Figure The West Doxorubicin Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Doxorubicin Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Doxorubicin Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Doxorubicin Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Doxorubicin Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Doxorubicin Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Doxorubicin Sales (K Units) and Growth Rate (2012-2022)
Figure United States Doxorubicin Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Doxorubicin Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Doxorubicin Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Doxorubicin Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Doxorubicin Sales Share by Players/Suppliers
Figure 2017 United States Doxorubicin Sales Share by Players/Suppliers
Figure United States Doxorubicin Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Doxorubicin Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Doxorubicin Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Doxorubicin Revenue Share by Players/Suppliers
Figure 2017 United States Doxorubicin Revenue Share by Players/Suppliers
Table United States Market Doxorubicin Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Doxorubicin Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Doxorubicin Market Share of Top 3 Players/Suppliers
Figure United States Doxorubicin Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Doxorubicin Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Doxorubicin Product Category
Table United States Doxorubicin Sales (K Units) by Region (2012-2017)
Table United States Doxorubicin Sales Share by Region (2012-2017)
Figure United States Doxorubicin Sales Share by Region (2012-2017)
Figure United States Doxorubicin Sales Market Share by Region in 2016
Table United States Doxorubicin Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Doxorubicin Revenue Share by Region (2012-2017)
Figure United States Doxorubicin Revenue Market Share by Region (2012-2017)
Figure United States Doxorubicin Revenue Market Share by Region in 2016
Table United States Doxorubicin Price (USD/Unit) by Region (2012-2017)
Table United States Doxorubicin Sales (K Units) by Type (2012-2017)
Table United States Doxorubicin Sales Share by Type (2012-2017)
Figure United States Doxorubicin Sales Share by Type (2012-2017)
Figure United States Doxorubicin Sales Market Share by Type in 2016
Table United States Doxorubicin Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Doxorubicin Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Doxorubicin by Type (2012-2017)
Figure Revenue Market Share of Doxorubicin by Type in 2016
Table United States Doxorubicin Price (USD/Unit) by Types (2012-2017)
Figure United States Doxorubicin Sales Growth Rate by Type (2012-2017)
Table United States Doxorubicin Sales (K Units) by Application (2012-2017)
Table United States Doxorubicin Sales Market Share by Application (2012-2017)
Figure United States Doxorubicin Sales Market Share by Application (2012-2017)
Figure United States Doxorubicin Sales Market Share by Application in 2016
Table United States Doxorubicin Sales Growth Rate by Application (2012-2017)
Figure United States Doxorubicin Sales Growth Rate by Application (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Doxorubicin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer Doxorubicin Sales Growth Rate (2012-2017)
Figure Pfizer Doxorubicin Sales Market Share in United States (2012-2017)
Figure Pfizer Doxorubicin Revenue Market Share in United States (2012-2017)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Doxorubicin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Johnson & Johnson Doxorubicin Sales Growth Rate (2012-2017)
Figure Johnson & Johnson Doxorubicin Sales Market Share in United States (2012-2017)
Figure Johnson & Johnson Doxorubicin Revenue Market Share in United States (2012-2017)
Table Sun Pharmaceutical Industries Basic Information List
Table Sun Pharmaceutical Industries Doxorubicin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sun Pharmaceutical Industries Doxorubicin Sales Growth Rate (2012-2017)
Figure Sun Pharmaceutical Industries Doxorubicin Sales Market Share in United States (2012-2017)
Figure Sun Pharmaceutical Industries Doxorubicin Revenue Market Share in United States (2012-2017)
Table Meiji Seika Pharma Basic Information List
Table Meiji Seika Pharma Doxorubicin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Meiji Seika Pharma Doxorubicin Sales Growth Rate (2012-2017)
Figure Meiji Seika Pharma Doxorubicin Sales Market Share in United States (2012-2017)
Figure Meiji Seika Pharma Doxorubicin Revenue Market Share in United States (2012-2017)
Table MicroBiopharm Japan Basic Information List
Table MicroBiopharm Japan Doxorubicin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure MicroBiopharm Japan Doxorubicin Sales Growth Rate (2012-2017)
Figure MicroBiopharm Japan Doxorubicin Sales Market Share in United States (2012-2017)
Figure MicroBiopharm Japan Doxorubicin Revenue Market Share in United States (2012-2017)
Table Teva Basic Information List
Table Teva Doxorubicin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Teva Doxorubicin Sales Growth Rate (2012-2017)
Figure Teva Doxorubicin Sales Market Share in United States (2012-2017)
Figure Teva Doxorubicin Revenue Market Share in United States (2012-2017)
Table Boryung Basic Information List
Table Boryung Doxorubicin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Boryung Doxorubicin Sales Growth Rate (2012-2017)
Figure Boryung Doxorubicin Sales Market Share in United States (2012-2017)
Figure Boryung Doxorubicin Revenue Market Share in United States (2012-2017)
Table Synbias Pharma Basic Information List
Table Synbias Pharma Doxorubicin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Synbias Pharma Doxorubicin Sales Growth Rate (2012-2017)
Figure Synbias Pharma Doxorubicin Sales Market Share in United States (2012-2017)
Figure Synbias Pharma Doxorubicin Revenue Market Share in United States (2012-2017)
Table Sterling Basic Information List
Table Sterling Doxorubicin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sterling Doxorubicin Sales Growth Rate (2012-2017)
Figure Sterling Doxorubicin Sales Market Share in United States (2012-2017)
Figure Sterling Doxorubicin Revenue Market Share in United States (2012-2017)
Table LINGNAN Pharmaceutical Basic Information List
Table LINGNAN Pharmaceutical Doxorubicin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure LINGNAN Pharmaceutical Doxorubicin Sales Growth Rate (2012-2017)
Figure LINGNAN Pharmaceutical Doxorubicin Sales Market Share in United States (2012-2017)
Figure LINGNAN Pharmaceutical Doxorubicin Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Doxorubicin
Figure Manufacturing Process Analysis of Doxorubicin
Figure Doxorubicin Industrial Chain Analysis
Table Raw Materials Sources of Doxorubicin Major Players/Suppliers in 2016
Table Major Buyers of Doxorubicin
Table Distributors/Traders List
Figure United States Doxorubicin Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Doxorubicin Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Doxorubicin Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Doxorubicin Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Doxorubicin Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Doxorubicin Sales Volume (K Units) Forecast by Type in 2022
Table United States Doxorubicin Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Doxorubicin Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Doxorubicin Sales Volume (K Units) Forecast by Application in 2022
Table United States Doxorubicin Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Doxorubicin Sales Volume Share Forecast by Region (2017-2022)
Figure United States Doxorubicin Sales Volume Share Forecast by Region (2017-2022)
Figure United States Doxorubicin Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources